Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""immunotherapy"" wg kryterium: Temat


Starter badań:

Tytuł:
The promise of sublingual and other immunotherapy options for infants and toddlers with food allergy.
Autorzy:
Anagnostou A; Department of Pediatrics, Section of Immunology, Allergy and Retrovirology, Texas Children's Hospital, Houston, Tex.
Upton JEM; Department of Paediatrics, Division of Immunology and Allergy, The Hospital for Sick Children, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Chinthrajah RS; Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford, Calif. Electronic address: .
Pokaż więcej
Źródło:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2024 Jan; Vol. 153 (1), pp. 95-97. Date of Electronic Publication: 2023 Nov 20.
Typ publikacji:
Editorial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Comment
MeSH Terms:
Food Hypersensitivity*/therapy
Sublingual Immunotherapy*
Child, Preschool ; Humans ; Administration, Sublingual ; Immunotherapy ; Desensitization, Immunologic ; Allergens
Raport
Tytuł:
Miniaturized CAR knocked onto CD3ε extends TCR function with CAR specificity under control of endogenous TCR signaling cascade.
Autorzy:
Manske K; Juno Therapeutics GmbH, A Bristol-Myers Squibb Company, Grillparzerstr. 10, Munich 81675, Germany.
Dreßler L; Juno Therapeutics GmbH, A Bristol-Myers Squibb Company, Grillparzerstr. 10, Munich 81675, Germany.
Fräßle SP; Juno Therapeutics GmbH, A Bristol-Myers Squibb Company, Grillparzerstr. 10, Munich 81675, Germany. Electronic address: .
Effenberger M; Juno Therapeutics GmbH, A Bristol-Myers Squibb Company, Grillparzerstr. 10, Munich 81675, Germany.
Tschulik C; Juno Therapeutics GmbH, A Bristol-Myers Squibb Company, Grillparzerstr. 10, Munich 81675, Germany.
Cletiu V; Juno Therapeutics GmbH, A Bristol-Myers Squibb Company, Grillparzerstr. 10, Munich 81675, Germany.
Benke E; Juno Therapeutics GmbH, A Bristol-Myers Squibb Company, Grillparzerstr. 10, Munich 81675, Germany.
Wagner M; Juno Therapeutics GmbH, A Bristol-Myers Squibb Company, Grillparzerstr. 10, Munich 81675, Germany.
Schober K; Institute for Medical Microbiology Immunology and Hygiene, Technical University of Munich, Munich, Germany.
Müller TR; Institute for Medical Microbiology Immunology and Hygiene, Technical University of Munich, Munich, Germany.
Stemberger C; Juno Therapeutics GmbH, A Bristol-Myers Squibb Company, Grillparzerstr. 10, Munich 81675, Germany.
Germeroth L; Juno Therapeutics GmbH, A Bristol-Myers Squibb Company, Grillparzerstr. 10, Munich 81675, Germany.
Busch DH; Institute for Medical Microbiology Immunology and Hygiene, Technical University of Munich, Munich, Germany.
Poltorak MP; Juno Therapeutics GmbH, A Bristol-Myers Squibb Company, Grillparzerstr. 10, Munich 81675, Germany; Institute for Medical Microbiology Immunology and Hygiene, Technical University of Munich, Munich, Germany.
Pokaż więcej
Źródło:
Journal of immunological methods [J Immunol Methods] 2024 Mar; Vol. 526, pp. 113617. Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:
Journal Article
MeSH Terms:
T-Lymphocytes*
Immunotherapy, Adoptive*/methods
Immunotherapy ; Receptors, Antigen, T-Cell
Czasopismo naukowe
Tytuł:
Neurotoxicity of Cancer Immunotherapies Including CAR T Cell Therapy.
Autorzy:
Song KW; Department of Neurology, Stanford University School of Medicine, 453 Quarry Rd, 2nd Floor, Stanford, CA, 94305, USA. .
Scott BJ; Department of Neurology, Stanford University School of Medicine, 453 Quarry Rd, 2nd Floor, Stanford, CA, 94305, USA.
Lee EQ; Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.
Pokaż więcej
Źródło:
Current neurology and neuroscience reports [Curr Neurol Neurosci Rep] 2023 Dec; Vol. 23 (12), pp. 827-839. Date of Electronic Publication: 2023 Nov 08.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunotherapy, Adoptive*/adverse effects
Neoplasms*/therapy
Humans ; Immunotherapy/adverse effects ; Immunotherapy/methods
Czasopismo naukowe
Tytuł:
Golden age of immunoengineering.
Autorzy:
Wong WW; Biomedical Engineering and Biological Design Center, Boston University, Boston, Massachusetts, USA.
Lim WA; Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California, USA.
Pokaż więcej
Źródło:
Immunological reviews [Immunol Rev] 2023 Nov; Vol. 320 (1), pp. 4-9. Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:
Journal Article
MeSH Terms:
Immunotherapy*
Neoplasms*
Humans ; Immunotherapy, Adoptive
Czasopismo naukowe
Tytuł:
Tracking adoptive natural killer cells via ultrasound imaging assisted with nanobubbles.
Autorzy:
Jiang Y; Department of Biomedical Engineering, The Hong Kong Polytechnic University, Room ST409 Hung Hom, Hong Kong SAR 999077, PR China.
Hou X; Department of Biomedical Engineering, The Hong Kong Polytechnic University, Room ST409 Hung Hom, Hong Kong SAR 999077, PR China.
Zhao X; Department of Biomedical Engineering, The Hong Kong Polytechnic University, Room ST409 Hung Hom, Hong Kong SAR 999077, PR China.
Jing J; Department of Biomedical Engineering, The Hong Kong Polytechnic University, Room ST409 Hung Hom, Hong Kong SAR 999077, PR China.
Sun L; Department of Biomedical Engineering, The Hong Kong Polytechnic University, Room ST409 Hung Hom, Hong Kong SAR 999077, PR China. Electronic address: .
Pokaż więcej
Źródło:
Acta biomaterialia [Acta Biomater] 2023 Oct 01; Vol. 169, pp. 542-555. Date of Electronic Publication: 2023 Aug 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunotherapy, Adoptive*/methods
Neoplasms*/diagnostic imaging
Neoplasms*/therapy
Humans ; Contrast Media ; Cell Line, Tumor ; Killer Cells, Natural ; Immunotherapy/methods
Czasopismo naukowe
Tytuł:
Cell Granularity Reflects Immune Cell Function and Enables Selection of Lymphocytes with Superior Attributes for Immunotherapy.
Autorzy:
Wu T; Department of Biomedical Engineering, Faculty of Engineering, National University of Singapore, Singapore, 117583, Singapore.; Institute for Health Innovation and Technology, National University of Singapore, Singapore, 117599, Singapore.
Tan JHL; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.
Sin WX; Critical Analytics for Manufacturing of Personalized Medicine, Singapore-MIT Alliance for Research and Technology, Singapore, 138602, Singapore.
Luah YH; Department of Biomedical Engineering, Faculty of Engineering, National University of Singapore, Singapore, 117583, Singapore.; Institute for Health Innovation and Technology, National University of Singapore, Singapore, 117599, Singapore.; Critical Analytics for Manufacturing of Personalized Medicine, Singapore-MIT Alliance for Research and Technology, Singapore, 138602, Singapore.
Tan SY; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.
Goh M; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.
Birnbaum ME; Critical Analytics for Manufacturing of Personalized Medicine, Singapore-MIT Alliance for Research and Technology, Singapore, 138602, Singapore.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Chen Q; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.
Cheow LF; Department of Biomedical Engineering, Faculty of Engineering, National University of Singapore, Singapore, 117583, Singapore.; Institute for Health Innovation and Technology, National University of Singapore, Singapore, 117599, Singapore.; Critical Analytics for Manufacturing of Personalized Medicine, Singapore-MIT Alliance for Research and Technology, Singapore, 138602, Singapore.
Pokaż więcej
Źródło:
Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2023 Oct; Vol. 10 (28), pp. e2302175. Date of Electronic Publication: 2023 Aug 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
CD8-Positive T-Lymphocytes*
Immunotherapy, Adoptive*
Immunotherapy ; CD4-Positive T-Lymphocytes ; Stem Cells
Czasopismo naukowe
Tytuł:
Genome Engineering for Next-Generation Cellular Immunotherapies.
Autorzy:
Park JJ; Department of Genetics, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520, United States.; System Biology Institute, Yale University, 850 West Campus Drive, West Haven, Connecticut 06516, United States.; Center for Cancer Systems Biology, Yale University, 850 West Campus Drive, West Haven, Connecticut 06516, United States.; M.D.-Ph.D. Program, Yale University, 333 Cedar Street, New Haven, Connecticut 06520, United States.; Molecular Cell Biology, Genetics, and Development Program, Yale University, 333 Cedar Street, New Haven, Connecticut 06520, United States.
Lee KAV; Department of Genetics, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520, United States.; System Biology Institute, Yale University, 850 West Campus Drive, West Haven, Connecticut 06516, United States.; Center for Cancer Systems Biology, Yale University, 850 West Campus Drive, West Haven, Connecticut 06516, United States.; Department of Biostatistics, Yale School of Public Health, 60 College Street, New Haven, Connecticut 06510, United States.
Lam SZ; Department of Genetics, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520, United States.; System Biology Institute, Yale University, 850 West Campus Drive, West Haven, Connecticut 06516, United States.; Center for Cancer Systems Biology, Yale University, 850 West Campus Drive, West Haven, Connecticut 06516, United States.
Tang K; Department of Genetics, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520, United States.; System Biology Institute, Yale University, 850 West Campus Drive, West Haven, Connecticut 06516, United States.; Center for Cancer Systems Biology, Yale University, 850 West Campus Drive, West Haven, Connecticut 06516, United States.
Chen S; Department of Genetics, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520, United States.; System Biology Institute, Yale University, 850 West Campus Drive, West Haven, Connecticut 06516, United States.; Center for Cancer Systems Biology, Yale University, 850 West Campus Drive, West Haven, Connecticut 06516, United States.; M.D.-Ph.D. Program, Yale University, 333 Cedar Street, New Haven, Connecticut 06520, United States.; Molecular Cell Biology, Genetics, and Development Program, Yale University, 333 Cedar Street, New Haven, Connecticut 06520, United States.; Immunobiology Program, Yale University, 333 Cedar Street, New Haven, Connecticut 06520, United States.; Yale Comprehensive Cancer Center, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520, United States.; Yale Stem Cell Center, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520, United States.; Yale Center for Biomedical Data Science, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520, United States.
Pokaż więcej
Źródło:
Biochemistry [Biochemistry] 2023 Dec 19; Vol. 62 (24), pp. 3455-3464. Date of Electronic Publication: 2022 Aug 05.
Typ publikacji:
Journal Article; Review; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunotherapy*
Neoplasms*/genetics
Neoplasms*/therapy
Humans ; Immunotherapy, Adoptive ; Cytokines ; Gene Editing ; Receptors, Antigen, T-Cell ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Process engineering of natural killer cell-based immunotherapy.
Autorzy:
Motallebnejad P; Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, MN 55455, USA.
Kantardjieff A; Bluebird Bio, Cambridge, MA 02142, USA.
Cichocki F; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Azarin SM; Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, MN 55455, USA.
Hu WS; Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: .
Pokaż więcej
Źródło:
Trends in biotechnology [Trends Biotechnol] 2023 Oct; Vol. 41 (10), pp. 1314-1326. Date of Electronic Publication: 2023 May 02.
Typ publikacji:
Journal Article; Review; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:
Immunotherapy, Adoptive*
Neoplasms*/therapy
Neoplasms*/metabolism
Humans ; Killer Cells, Natural/metabolism ; Immunotherapy ; T-Lymphocytes
Czasopismo naukowe
Tytuł:
Cancer immunotherapies: advances and bottlenecks.
Autorzy:
Rui R; Department of Urology, Peking University First Hospital, Beijing, China.; The Institution of Urology, Peking University, Beijing, China.; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, China.; National Urological Cancer Center, Beijing, China.
Zhou L; Department of Urology, Peking University First Hospital, Beijing, China.; The Institution of Urology, Peking University, Beijing, China.; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, China.; National Urological Cancer Center, Beijing, China.
He S; Department of Urology, Peking University First Hospital, Beijing, China.; The Institution of Urology, Peking University, Beijing, China.; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, China.; National Urological Cancer Center, Beijing, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Aug 24; Vol. 14, pp. 1212476. Date of Electronic Publication: 2023 Aug 24 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunotherapy*
Neoplasms*/therapy
Immunomodulation ; Immunity, Active ; Immunotherapy, Adoptive ; Adoptive Transfer
Czasopismo naukowe
Tytuł:
Natural killer cell therapy targeting cancer stem cells: Old wine in a new bottle.
Autorzy:
Guo F; Cancer Center, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, China.
Zhang Y; Cancer Center, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, China.
Bai L; Cancer Center, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, China.
Cui J; Cancer Center, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, China. Electronic address: .
Pokaż więcej
Źródło:
Cancer letters [Cancer Lett] 2023 Aug 28; Vol. 570, pp. 216328. Date of Electronic Publication: 2023 Jul 26.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunotherapy, Adoptive*/methods
Neoplasms*/pathology
Humans ; Killer Cells, Natural ; Immunotherapy/methods ; Neoplastic Stem Cells/metabolism
Czasopismo naukowe
Tytuł:
New immunotherapeutic approaches for cancer treatment.
Autorzy:
Kamrani A; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Science, Tabriz, Iran.
Hosseinzadeh R; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Shomali N; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Science, Tabriz, Iran.
Heris JA; Department of Allergy and Clinical Immunology, Pediatric Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
Shahabi P; Department of Physiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Mohammadinasab R; Department of History of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Sadeghvand S; Pediatrics Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: .
Ghahremanzadeh K; Department of Pathology, Tabriz University of Medical Sciences, Tabriz, Iran.
Sadeghi M; Department of molecular medicine, Tabriz University of Medical Science, Tabriz, Iran.
Akbari M; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: .
Pokaż więcej
Źródło:
Pathology, research and practice [Pathol Res Pract] 2023 Aug; Vol. 248, pp. 154632. Date of Electronic Publication: 2023 Jun 19.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunotherapy*
Neoplasms*/therapy
Humans ; Immune Checkpoint Inhibitors ; Immunotherapy, Adoptive ; Cancer Vaccines ; Precision Medicine
Czasopismo naukowe
Tytuł:
Improvement of daily allergy control by sublingual immunotherapy: A MASK-air® study.
Autorzy:
Bousquet J; Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.; University Hospital Montpellier, Montpellier, France.
Sousa-Pinto B; MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences; Faculty of Medicine, University of Porto, Porto, Portugal.; , Faculty of Medicine, University of Porto, Porto, Portugal.
Shamji MH; National Heart and Lung Institute, Imperial College, London, UK.; NIHR Imperial Biomedical Research Centre, London, UK.
Anto JM; ISGlobal. ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
Klimek L; Department of Otolaryngology, Head and Neck Surgery, Universitätsmedizin Mainz, Mainz, Germany.; Center for Rhinology and Allergology, Wiesbaden, Germany.
Canonica GW; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; IRCCS Humanitas Research Center, Personalized medicine, Asthma and Allergy, Milan, Italy.
Czarlewski W; Medical Consulting Czarlewski, Levallois, France.
Devillier P; VIM Suresnes, UMR 0892, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France.
Haahtela T; Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.
Laune D; KYomed INNOV, Montpellier, France.
Mullol J; Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, Barcelona, Spain.; Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
Brussino L; Department of Medical Sciences, University of Torino, Torino, Italy.; Allergy and Clinical Immunology Unit, Mauriziano Hospital, Torino, Italy.
Cecchi L; SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy.
Kvedariene V; Institute of Clinical Medicine, Clinic of Chest Diseases and Allergology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.; Department of Pathology, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, Vilnius, Lithuania.
Morais-Almeida M; Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal.
Mösges R; Institute of Medical Statistics and Computational Biology, University of Cologne and ClinCompetence Cologne GmbH, Cologne, Germany.
Niedoszytko M; Department of Allergology, Medical University of Gdańsk, Gdansk, Poland.
Papadopoulos NG; Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece.
Patella V; Division of Allergy and Clinical Immunology, Department of Medicine, 'Santa Maria della Speranza' Hospital, Agency of Health ASL, Salerno, Italy.; Postgraduate Program in Allergy and Clinical Immunology, University of Naples Federico II, Naples, Italy.
Pham-Thi N; Ecole Polytechnique de Palaiseau, Palaiseau, France.; IRBA (Institut de Recherche Bio-Médicale des Armées), Brétigny sur Orge, France.; Université Paris Cité, Paris, France.
Samolinski B; Department of Prevention of Environmental Hazards, Allergology and Immunology, Medical University of Warsaw, Warsaw, Poland.
Taborda-Barata L; Department of Immunoallergology, Cova da Beira University Hospital Centre, Covilhã, Portugal.; UBIAir-Clinical & Experimental Lung Centre and CICS-UBI Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.
Toppila-Salmi S; Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.
Sastre J; Allergy Service, Fundacion Jimenez Diaz, Autonoma University of Madrid, CIBERES-ISCIII, Madrid, Spain.
Valiulis A; Institute of Clinical Medicine and Institute of Health Sciences, Vilnius, Lithuania.; Medical Faculty of Vilnius University, Vilnius, Lithuania.
Ventura MT; Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.; Institute of Sciences of Food Production, National Research Council (ISPA-CNR), Bari, Italy.
Jutel M; Department of Clinical Immunology, Wrocław Medical University, ALL-MED Medical Research Institute, Wroclaw, Poland.
Kuna P; Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
Valovirta E; Department of Lung Diseases and Clinical Allergology, University of Turku, Turku, Finland.
Zuberbier T; Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
Fonseca JA; MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences; Faculty of Medicine, University of Porto, Porto, Portugal.; , Faculty of Medicine, University of Porto, Porto, Portugal.
Pfaar O; Section of Rhinology and Allergy, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
Pokaż więcej
Źródło:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2023 Aug; Vol. 53 (8), pp. 854-861. Date of Electronic Publication: 2023 Apr 17.
Typ publikacji:
Letter
MeSH Terms:
Sublingual Immunotherapy*/adverse effects
Hypersensitivity*/therapy
Humans ; Desensitization, Immunologic ; Allergens ; Immunotherapy
Opinia redakcyjna
Tytuł:
CAR T-Cell Therapy for Cancer: Latest Updates and Challenges, with a Focus on B-Lymphoid Malignancies and Selected Solid Tumours.
Autorzy:
Tang HKC; Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK.
Wang B; University of Cambridge, Trinity Hall, Cambridge CB3 9DP, UK.
Tan HX; Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK.
Sarwar MA; Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK.
Baraka B; Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK.
Shafiq T; Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK.
Rao AR; Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Jun 08; Vol. 12 (12). Date of Electronic Publication: 2023 Jun 08.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunotherapy, Adoptive*/adverse effects
Neuroblastoma*/pathology
Humans ; Receptors, Antigen, T-Cell/metabolism ; T-Lymphocytes ; Immunotherapy ; CD3 Complex/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
The past, present, and future of immunotherapy for endometrial adenocarcinoma.
Autorzy:
Jones AC; Department of Microbiology, Immunology & Pathology, Des Moines University College of Osteopathic Medicine, Des Moines, IA, 50312, USA.; Department of Surgery, University of Missouri School of Medicine, Columbia, MO, 65212, USA.
Brown KH; Department of Microbiology, Immunology & Pathology, Des Moines University College of Osteopathic Medicine, Des Moines, IA, 50312, USA.; Department of Surgery, University of Missouri School of Medicine, Columbia, MO, 65212, USA.
Guan T; Department of Obstetrics and Gynecology, The Nanhua Hospital Affiliated to Nanhua University, Hengyang, China.
Smith LA; Department of Surgery, University of Missouri School of Medicine, Columbia, MO, 65212, USA.
Formslag CR; Department of Microbiology, Immunology & Pathology, Des Moines University College of Osteopathic Medicine, Des Moines, IA, 50312, USA.
Farjado ED; Department of Surgery, University of Missouri School of Medicine, Columbia, MO, 65212, USA.
Bai Q; Department of Surgery, University of Missouri School of Medicine, Columbia, MO, 65212, USA.
Luechtefeld HD; Department of Surgery, University of Missouri School of Medicine, Columbia, MO, 65212, USA.
Wakefield MR; Department of Surgery, University of Missouri School of Medicine, Columbia, MO, 65212, USA.
Dong L; Department of Obstetrics and Gynecology, The Nanhua Hospital Affiliated to Nanhua University, Hengyang, China. .
Fang Y; Department of Microbiology, Immunology & Pathology, Des Moines University College of Osteopathic Medicine, Des Moines, IA, 50312, USA. .; Department of Surgery, University of Missouri School of Medicine, Columbia, MO, 65212, USA. .
Pokaż więcej
Źródło:
Medical oncology (Northwood, London, England) [Med Oncol] 2023 May 23; Vol. 40 (7), pp. 186. Date of Electronic Publication: 2023 May 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunotherapy*
Adenocarcinoma*
Humans ; Female ; Immunotherapy, Adoptive ; Hysterectomy ; Vaccination
Czasopismo naukowe
Tytuł:
Biological Insight and Recent Advancement in the Treatment of Neuroblastoma.
Autorzy:
Rivera Z; Division of Pediatric Surgery, Department of Surgery, Rush University Medical Center, Chicago, IL 60612, USA.
Escutia C; Division of Pediatric Surgery, Department of Surgery, Rush University Medical Center, Chicago, IL 60612, USA.
Madonna MB; Division of Pediatric Surgery, Department of Surgery, Rush University Medical Center, Chicago, IL 60612, USA.
Gupta KH; Division of Pediatric Surgery, Department of Surgery, Rush University Medical Center, Chicago, IL 60612, USA.; Division of Surgical Oncology, Department of Surgery, Rush University Medical Center, Chicago, IL 60612, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 09; Vol. 24 (10). Date of Electronic Publication: 2023 May 09.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunotherapy, Adoptive*/methods
Neuroblastoma*/genetics
Neuroblastoma*/therapy
Neuroblastoma*/metabolism
Infant, Newborn ; Child ; Humans ; N-Myc Proto-Oncogene Protein/genetics ; Immunotherapy/methods ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł:
The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022.
Autorzy:
Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy. .
Brentjens R; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Khleif SN; The Loop Immuno Oncology Laboratory, Georgetown University Medical School, Washington, DC, USA.
Odunsi K; University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA.
Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ruella M; Center for Cellular Immunotherapies and Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Sullivan RJ; Melanoma Program, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Fox BA; Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Cancer Institute, Portland, OR, USA.
Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2023 Apr 22; Vol. 21 (1), pp. 275. Date of Electronic Publication: 2023 Apr 22.
Typ publikacji:
Journal Article
MeSH Terms:
Immunotherapy*
Neoplasms*/therapy
Humans ; Immunotherapy, Adoptive ; T-Lymphocytes ; Biomarkers, Tumor ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies.
Autorzy:
Faeq MH; Student of General Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Al-Haideri M; Department of Physiotherapy, Cihan University-Erbil, Kurdistan Region, Erbil, Iraq.
Mohammad TAM; Department of Pharmacology, College of Pharmacy, Hawler Medical University, Kurdistan Region, Erbil, Iraq.
Gharebakhshi F; Department of Radiology, School of Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Marofi F; Department of Hematology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Tahmasebi S; Student Research Committee, Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .
Modaresahmadi S; Department of Immunology and Biotechnology, Texas Tech University Health Siences Center, Abilene, TX, USA.
Pokaż więcej
Źródło:
Medical oncology (Northwood, London, England) [Med Oncol] 2023 Apr 21; Vol. 40 (5), pp. 155. Date of Electronic Publication: 2023 Apr 21.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunotherapy*/methods
Neoplasms*/therapy
Humans ; Immunotherapy, Adoptive/methods ; T-Lymphocytes, Cytotoxic ; Antigens, Neoplasm ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Apoptosis: a Janus bifrons in T-cell immunotherapy.
Autorzy:
Lee YG; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-do, Republic of Korea.
Yang N; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Chun I; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Porazzi P; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Carturan A; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Paruzzo L; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Department of Oncology, University of Turin, Torino, Piemonte, Italy.
Sauter CT; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Guruprasad P; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Pajarillo R; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Ruella M; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA .; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Apr; Vol. 11 (4).
Typ publikacji:
Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunotherapy*/methods
Neoplasms*/therapy
Humans ; Immunotherapy, Adoptive/methods ; T-Lymphocytes, Cytotoxic ; Apoptosis ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Tumor therapeutic response monitored by telemetric temperature sensing, a preclinical study on immunotherapy and chemotherapy.
Autorzy:
Shao Q; Department of Mechanical Engineering, University of Minnesota, Minneapolis, USA. .
Lundgren M; Department of Radiology, University of Minnesota, Minneapolis, USA.
Lynch J; School of Medicine, University of Minnesota, Minneapolis, USA.
Jiang M; Department of Biomedical Engineering, University of Minnesota, Minneapolis, USA.
Mir M; School of Medicine, University of Minnesota, Minneapolis, USA.
Bischof J; Department of Mechanical Engineering, University of Minnesota, Minneapolis, USA.; Department of Biomedical Engineering, University of Minnesota, Minneapolis, USA.
Nelson M; Department of Radiology, University of Minnesota, Minneapolis, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 May 12; Vol. 13 (1), pp. 7727. Date of Electronic Publication: 2023 May 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunotherapy*
Melanoma*/pathology
Animals ; Temperature ; T-Lymphocytes/pathology ; Immunotherapy, Adoptive/methods ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies.
Autorzy:
Huang S; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang X; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Wang Y; The First School of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Wang Y; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Fang C; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Wang Y; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.; School of Rehabilitation Sciences, Southern Medical University, Guangzhou, China.
Chen S; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chen R; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Lei T; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Zhang Y; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Xu X; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. .
Li Y; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. .; Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, China. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2023 May 06; Vol. 22 (1), pp. 80. Date of Electronic Publication: 2023 May 06.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunotherapy, Adoptive*/adverse effects
Receptors, Antigen, T-Cell*/genetics
Humans ; Immunotherapy
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies